Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFTAZIDIME vs CEFTOLOZANE\TAZOBACTAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFTAZIDIME vs CEFTOLOZANE\TAZOBACTAM: Safety Overview

Metric CEFTAZIDIME CEFTOLOZANE\TAZOBACTAM
Total FAERS Reports 3,158 1,098
Deaths Reported 696 259
Death Rate 22.0% 23.6%
Hospitalizations 1,503 327
Average Patient Age 52.0 yrs 55.9 yrs
% Female Patients 43.3% 38.2%
FDA Approval Date Apr 28, 1989 N/A
Manufacturer Hospira, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A